Innovation, Transformation, Globalization - New Paradigms for Pharmaceutical Technology, Quality and Compliance in China
Join 2016 ISPE China Annual Spring Conference and Understand how you can integrate regulation, technology and quality to drive increased production and operational effectiveness.
Keynote Speech:
David Churchward, official from MHRA will talk about Data Integrity in plenary session!
Conference tracks will include:
• Regulatory, Quality and Compliance
• Manufacturing and Engineering
• Chemical Drug Product and Manufacturing Process
• Biological Drug Product Development and Manufacturing
• Clinical Supplies
Concurrent events
• Bio Pre-workshop
• Facility Tour
• Reception
Why attend?
• To discuss with corporate executives and experts on the business impact from the regulatory changes; to probe into new ideas with a clearer direction.
• To provide knowledge sharing and information exchange with delegates from flagship enterprises; to explore, learn and understand the key attributes towards better quality and compliance.
• To utilize the ISPE platform and the applications of its guidance for the effective management of pharmaceutical production, for greater regulatory compliance and management skills within the Chinese pharmaceutical industry.
Who shall attend?
• Decision makers at senior and middle management levels, the technical leaders and professionals responsible for drugs development in R&D, Regulatory Affairs, Clinical Development, Process Development, Analytical Development, Drug Manufacturing and QA&QC from manufacturers;
• General Managers, Chief engineers, Directors, Project Managers from design institute, engineering and project management companies, and pharmaceutical equipment & instrument manufacturers.
Apr 11
2016
Apr 12
2016
Registration deadline
Submit Comment